Abstract
An isotropic expanded Planning Target Volume (PTV) neglects patient’s off-axis rotation. This study designs a rotational PTV that is used instead of the standard 3-mm Clinical Target Volume (CTV) expanded PTV in oropharyngeal cancers with the goal to reduce pharyngeal constrictor muscle (PCM) mean dose. 10 patients were retrospectively evaluated. For off-axis rotation, the image was rotated around the longitudinal axis (cervical spinal canal) ± 5 degrees. These new CTVs were combined to form the rotational PTV. The standard and rotational treatment plans were designed with the goal to keep the superior and middle PCM-CTV70 mean dose to less than 50 Gy. There were a 355 cGy reduction in the superior PCM mean dose (form 5332 to 4977 cGy) and a 506 cGy reduction in middle PCM mean dose (from 4185 to 3679 cGy). 60% of patients may have at least a 20% reduction in dysphagia probability based on a Normal Tissue Complication Probability (NTCP) formula. The superior and middle PCM mean dose were reduced to less than 50 Gy in 40 and 20% of cases. There was an association between superior PCM mean dose and overlap volume of PTV70 and superior PCM in both standard (r = 0.92, p = 0.001) and rotational (r = 0.84, p = 0.002) plans. This association was present for middle PCM and PTV70 (r = 0.52, p = 0.02 and r = 0.62, p = 0.006). Rotational PTV can lower the mean dose to superior and middle PCMs, ultimately leading to lower dysphagia rates.
Similar content being viewed by others
Abbreviations
- CTV:
-
Clinical target volume
- GTV:
-
Gross tumor volume
- ICRU:
-
International commission on radiation units and measurements
- IMRT:
-
Intensity modulated radiation therapy
- IRB:
-
Institutional review board
- MDADI:
-
MD Anderson dysphagia inventory
- NTCP:
-
Normal tissue complication probability
- OAR:
-
Organ at risk
- PCM:
-
Pharyngeal constrictor muscle
- PEG:
-
Percutaneous endoscopic gastrostomy
- PTV:
-
Planning target volume
- RTOG:
-
Radiation therapy oncology group
- VMAT:
-
Volumetric modulated arc therapy
References
Gupta T, Sinha S, Ghosh-Laskar S, et al. Intensity-modulated radiation therapy versus three-dimensional conformal radiotherapy in head and neck squamous cell carcinoma: long-term and mature outcomes of a prospective randomized trial. Radiat Oncol. 2020;15(1):218. https://doi.org/10.1186/s13014-020-01666-5.
Spiotto MT, Weichselbaum RR. Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers. PLoS ONE. 2014;9(4): e94456. https://doi.org/10.1371/journal.pone.0094456.
van Kranen S, Hamming-Vrieze O, Wolf A, Damen E, van Herk M, Sonke JJ. Head and neck margin reduction with adaptive radiation therapy: robustness of treatment plans against anatomy changes. Int J Radiat Oncol Biol Phys. 2016;96(3):653–60. https://doi.org/10.1016/j.ijrobp.2016.07.011.
Platteaux N, Dirix P, Dejaeger E, Nuyts S. Dysphagia in head and neck cancer patients treated with chemoradiotherapy. Dysphagia. 2010;25(2):139–52. https://doi.org/10.1007/s00455-009-9247-7.
Nguyen NP, Moltz CC, Frank C, et al. Dysphagia following chemoradiation for locally advanced head and neck cancer. Annals Oncol Off J Eur Soc Med Oncol. 2004;15(3):383–8. https://doi.org/10.1093/annonc/mdh101.
Nguyen NP, Frank C, Moltz CC, et al. Aspiration rate following chemoradiation for head and neck cancer: an underreported occurrence. Radiother Oncol. 2006;80(3):302–6. https://doi.org/10.1016/j.radonc.2006.07.031.
Xu B, Boero IJ, Hwang L, et al. Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer. Cancer. 2015;121(8):1303–11. https://doi.org/10.1002/cncr.29207.
Awan MJ, Mohamed AS, Lewin JS, et al. Late radiation-associated dysphagia (late-RAD) with lower cranial neuropathy after oropharyngeal radiotherapy: a preliminary dosimetric comparison. Oral Oncol. 2014;50(8):746–52. https://doi.org/10.1016/j.oraloncology.2014.05.003.
Patterson JM, Rapley T, Carding PN, Wilson JA, McColl E. Head and neck cancer and dysphagia; caring for carers. Psychooncology. 2013;22(8):1815–20. https://doi.org/10.1002/pon.3226.
Nguyen NP, Frank C, Moltz CC, et al. Impact of dysphagia on quality of life after treatment of head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2005;61(3):772–8. https://doi.org/10.1016/j.ijrobp.2004.06.017.
Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004;60(5):1425–39. https://doi.org/10.1016/j.ijrobp.2004.05.050.
Hunter KU, Lee OE, Lyden TH, et al. Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors. Head Neck. 2014;36(1):120–5. https://doi.org/10.1002/hed.23275.
Langendijk JA, Doornaert P, Verdonck-de Leeuw IM, Leemans CR, Aaronson NK, Slotman BJ. Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(22):3770–6. https://doi.org/10.1200/jco.2007.14.6647.
Christianen ME, Schilstra C, Beetz I, et al. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study. Radiother Oncol. 2012;105(1):107–14. https://doi.org/10.1016/j.radonc.2011.08.009.
Eisbruch A, Kim HM, Feng FY, et al. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates. Int J Radiat Oncol Biol Phys. 2011;81(3):e93–9. https://doi.org/10.1016/j.ijrobp.2010.12.067.
Christianen ME, van der Schaaf A, van der Laan HP, et al. Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach. Radiother Oncol. 2016;118(2):298–303. https://doi.org/10.1016/j.radonc.2015.11.009.
Nutting C, Rooney K, Foran B, et al. Results of a randomized phase III study of dysphagia-optimized intensity modulated radiotherapy (Do-IMRT) versus standard IMRT (S-IMRT) in head and neck cancer. J Clin Oncol. 2020;38(15):6508–608. https://doi.org/10.1200/JCO.2020.38.15_suppl.6508.
Hodapp N. The ICRU Report 83: prescribing, recording and reporting photon-beam intensity-modulated radiation therapy (IMRT). Strahlenther Onkol. 2012;188(1):97–9. https://doi.org/10.1007/s00066-011-0015-x.
Swartz EE, Floyd RT, Cendoma M. Cervical spine functional anatomy and the biomechanics of injury due to compressive loading. J Athl Train. 2005;40(3):155–61.
Kuo C, Fanton M, Wu L, Camarillo D. Spinal constraint modulates head instantaneous center of rotation and dictates head angular motion. J Biomech. 2018;76:220–8.
Guckenberger M, Meyer J, Vordermark D, Baier K, Wilbert J, Flentje M. Magnitude and clinical relevance of translational and rotational patient setup errors: a cone-beam CT study. Int J Radiat Oncol Biol Phys. 2006;65(3):934–42. https://doi.org/10.1016/j.ijrobp.2006.02.019.
Van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47(4):1121–35.
Arbab M, Ai H, Bartlett G, Dawson B, Langer M. The effect of designing a rotational planning target volume on sparing pharyngeal constrictor muscles in patients with oropharyngeal cancer. J Appl Clin Med Phys. 2020. https://doi.org/10.1002/acm2.13052.
Christianen ME, Langendijk JA, Westerlaan HE, van de Water TA, Bijl HP. Delineation of organs at risk involved in swallowing for radiotherapy treatment planning. Radiother Oncol. 2011;101(3):394-402 doi: https://doi.org/10.1016/j.radonc.2011.05.015
Mazzola R, Ricchetti F, Fiorentino A, et al. Dose-volume-related dysphagia after constrictor muscles definition in head and neck cancer intensity-modulated radiation treatment. Br J Radiol. 2014;87(1044):20140543. https://doi.org/10.1259/bjr.20140543.
Rancati T, Schwarz M, Allen AM, et al. Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys. 2010;76(3 Suppl):S64–9. https://doi.org/10.1016/j.ijrobp.2009.03.079.
Petkar I, Rooney K, Roe JW, et al. DARS: a phase III randomised multicentre study of dysphagia- optimised intensity- modulated radiotherapy (Do-IMRT) versus standard intensity- modulated radiotherapy (S-IMRT) in head and neck cancer. BMC Cancer. 2016;16(1):770. https://doi.org/10.1186/s12885-016-2813-0.
van der Laan HP, Gawryszuk A, Christianen ME, et al. Swallowing-sparing intensity-modulated radiotherapy for head and neck cancer patients: treatment planning optimization and clinical introduction. Radiother Oncol. 2013;107(3):282–7. https://doi.org/10.1016/j.radonc.2013.05.004.
Djordjevic M, Sjöholm E, Tullgren O, Sorcini B. Assessment of residual setup errors for anatomical sub-structures in image-guided head-and-neck cancer radiotherapy. Acta Oncol. 2014;53(5):646–53. https://doi.org/10.3109/0284186x.2013.862593.
Funding
Mona Arbab received American College of Radiation Oncology Resident Seed Grant in 2020 for this project. Mark Langer and Jeffrey Ge have received the NIH R03 (CA249545) Grant for this project.
Author information
Authors and Affiliations
Contributions
All authors contributed to the study conception and design. The study design was performed by MA, JG, and ML. The material preparation, data collection, and analysis were performed by MA, GB, and BD. The first draft of the manuscript was written by MA and ML and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The author declare that they have no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Arbab, M., Bartlett, G., Dawson, B. et al. The Dosimetric Outcome of a Rotational Planning Target Volume in Patients With Oropharyngeal Cancers. Dysphagia 37, 848–855 (2022). https://doi.org/10.1007/s00455-021-10341-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00455-021-10341-0